Quick Answer
Actinium Pharmaceuticals, Inc. reported Shares Outstanding of 31.20 million shares for fiscal year 2025.
Actinium Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.20M | +0.0% |
| 2024 | 31.20M | +12.9% |
| 2023 | 27.63M | +7.6% |
| 2022 | 25.67M | +15.9% |
| 2021 | 22.14M | +26.3% |
| 2020 | 17.53M | +219.4% |
| 2019 | 5.49M | -95.3% |
| 2018 | 115.70M | +44.5% |
| 2017 | 80.07M | +43.5% |
| 2016 | 55.80M | +26.6% |
| 2015 | 44.07M | +47.0% |
| 2014 | 29.97M | +22.0% |
| 2013 | 24.57M | +14.8% |
| 2012 | 21.39M | +56.5% |
| 2011 | 13.66M | +22.5% |
| 2010 | 11.16M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 31.20M | +0.0% | +0.0% |
| June 30, 2025 | 31.20M | +2.1% | +0.0% |
| March 31, 2025 | 31.20M | +6.1% | +0.0% |
| December 31, 2024 | 31.20M | +12.9% | +0.0% |
| September 30, 2024 | 31.20M | +13.8% | +2.1% |
| June 30, 2024 | 30.55M | +13.2% | +3.9% |
| March 31, 2024 | 29.40M | +14.3% | +6.4% |
| December 31, 2023 | 27.63M | +7.6% | +0.8% |
- Actinium Pharmaceuticals, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Actinium Pharmaceuticals, Inc.’s shares outstanding has grown by 179.7% (from 11.16 million shares to 31.20 million shares).
- The most recent figure is from Actinium Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: